Articles published by Amneal Pharmaceuticals, Inc.
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval
December 20, 2022
Via Business Wire
Tickers
AMRX
Amneal to Participate at Upcoming Investor Conferences
November 23, 2022
Via Business Wire
Tickers
AMRX
Amneal Launches Second Biosimilar with RELEUKO® (filgrastim-ayow) in the United States
November 22, 2022
Via Business Wire
Tickers
AMRX
Amneal Reports Third Quarter 2022 Financial Results
November 04, 2022
Via Business Wire
Tickers
AMRX
Amneal Receives FDA Approval for Leuprolide Acetate Injection
November 02, 2022
Via Business Wire
Tickers
AMRX
Amneal Expands Leadership Team with Appointment of Senior Leaders in Quality and Regulatory
October 31, 2022
Via Business Wire
Tickers
AMRX
Amneal to Report Third Quarter 2022 Results on November 4, 2022
October 06, 2022
Via Business Wire
Tickers
AMRX
Amneal Launches First Biosimilar with ALYMSYS® (bevacizumab-maly) in the United States
October 03, 2022
Via Business Wire
Tickers
AMRX
Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer – Specialty
September 06, 2022
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Amneal Appoints Deborah M. Autor to Board of Directors
August 03, 2022
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Amneal to Report First Quarter 2022 Results on May 4, 2022
April 07, 2022
Via Business Wire
Tickers
AMRX
Amneal Expands Injectables Portfolio with 4 New Products
February 17, 2022
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free